Physician profile
Christine Lurie
NPI 1073005567
$6,333.85
in general payments reported to CMS, 2019-2025
16 companies · $5,852 in 2025
The $5,852 reported for 2025 was more than what 93% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $134 · 2024: $348 · 2025: $5,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,769 · Food and Beverage: $1,121 · Travel and Lodging: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,768.98 |
| Food and Beverage | $1,121.10 |
| Travel and Lodging | $443.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,005.30 | 2025 | |
| Astellas Pharma US INC | $452.45 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $144.11 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Abbvie INC. | $117.00 | 2025 | |
| Shield Therapeutics INC | $116.00 | 2024-2025 | |
| Pfizer INC. | $104.38 | 2024-2025 | |
| Daiichi Sankyo INC. | $87.36 | 2024-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $83.65 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $63.13 | 2024-2025 | |
| Novo Nordisk INC | $43.67 | 2024-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $27.73 | 2025 | Keytruda |
| Optumhealth Care Solutions, LLC | $21.15 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Organon LLC | $18.61 | 2025 | Jada System |
| Solventum Corporation | $17.58 | 2025 | Prevena |
| Coopersurgical, INC. | $17.00 | 2023 | Paragard T 380a |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $14.73 | 2024 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Lurie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.